Jiamei Yang
- Hepatology top 0.5%
- Epidemiology top 5%
- Cancer Research top 5%
- Surgery top 5%
- Oncology top 5%
- Co-authors
- Yanming ZhouWon Young TakJordi BruixJosep M. LlovetGerold MeinhardtGar-Yang ChauChengjun SuiBin Li
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (28 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers)Liver Disease Diagnosis and Treatment (8 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Jiamei Yang
48 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 1.7k
- Epidemiology 801
- Cancer Research 616
- Surgery 577
- Oncology 538
Countries citing papers authored by Jiamei Yang
This map shows the geographic impact of Jiamei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiamei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiamei Yang more than expected).
Fields of papers citing papers by Jiamei Yang
This network shows the impact of papers produced by Jiamei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiamei Yang. The network helps show where Jiamei Yang may publish in the future.
Co-authorship network of co-authors of Jiamei Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Jiamei Yang. A scholar is included among the top collaborators of Jiamei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiamei Yang. Jiamei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 17 | |
| 3 | 18 | |
| 4 | 85 | |
| 5 | Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialbreakdown → | 479 |
| 6 | Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trialbreakdown → | 771 |
| 7 | 25 | |
| 8 | Is postoperative adjuvant transchatheter arterial chemoembolization necessary for small hepatocellular carcinoma patients: a randomized controlled trial | 4 |
| 9 | 86 | |
| 10 | 19 | |
| 11 | 24 | |
| 12 | 10 | |
| 13 | Combination of thymosin-α_1 with low-dose gemcitabine for advanced non-small cell lung cancer in elderly patients | 3 |
| 14 | Clinical study of comparative efficacy of DCF regimen vs. ECF regimen in treating advanced gastric cancer | 1 |
| 15 | 92 | |
| 16 | Recent Advances and Controversies in Surgical Management of Hepatocellular Carcinoma | 0 |
| 17 | [The effect of postoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma]. | 1 |
| 18 | 1 | |
| 19 | Resection of caudate lobe carcinoma of the liver | 0 |
| 20 | 96 |
About Jiamei Yang
Jiamei Yang is a scholar working on Hepatology, Cancer Research and Pathology and Forensic Medicine, having authored 51 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Hepatology (1.7k citations), Cancer Research (616 citations) and Pathology and Forensic Medicine (506 citations). Jiamei Yang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yanming Zhou, Won Young Tak, Jordi Bruix, Josep M. Llovet, Gerold Meinhardt, Gar-Yang Chau, Chengjun Sui, Bin Li, Zhengfeng Yin and Kwan Sik Lee. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.